GlassScriptPhysician profile
Spencer Woolen
NPI 1962014894
$1,992.52
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,275 · 2022: $717.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $616.18 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $311.21 | 2021-2022 | |
| Janssen Biotech, INC. | $198.93 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $197.99 | 2021-2022 | |
| Celgene Corporation | $173.01 | 2021-2022 | |
| Gilead Sciences, INC. | $116.76 | 2021-2022 | |
| Redhill Biopharma INC. | $81.45 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $71.66 | 2021-2022 | |
| Qol Medical, LLC | $53.14 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $24.39 | 2022 | |
| Ironwood Pharmaceuticals, INC | $24.27 | 2021 | |
| Pfizer INC. | $24.05 | 2022 | |
| Organon LLC | $19.81 | 2021 | |
| Braintree Laboratories, INC. | $19.80 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $18.18 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $15.28 | 2021 | |
| Daiichi Sankyo INC. | $13.58 | 2021 | |
| Olympus America INC. | $12.83 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spencer Woolen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.